Xponance Inc. Acquires 20,252 Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Xponance Inc. increased its holdings in Celsius Holdings, Inc. (NASDAQ:CELH) by 186.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,113 shares of the company’s stock after acquiring an additional 20,252 shares during the quarter. Xponance Inc.’s holdings in Celsius were worth $1,696,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of the business. AIA Group Ltd increased its stake in shares of Celsius by 302.1% in the 4th quarter. AIA Group Ltd now owns 18,900 shares of the company’s stock worth $1,030,000 after acquiring an additional 14,200 shares in the last quarter. Cambridge Trust Co. increased its stake in shares of Celsius by 280.0% in the 4th quarter. Cambridge Trust Co. now owns 570 shares of the company’s stock worth $31,000 after acquiring an additional 420 shares in the last quarter. Oliver Lagore Vanvalin Investment Group increased its stake in shares of Celsius by 443.6% in the 4th quarter. Oliver Lagore Vanvalin Investment Group now owns 13,801 shares of the company’s stock worth $752,000 after acquiring an additional 11,262 shares in the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Celsius by 388.1% in the 4th quarter. Daiwa Securities Group Inc. now owns 16,375 shares of the company’s stock worth $892,000 after acquiring an additional 13,020 shares in the last quarter. Finally, Phoenix Wealth Advisors increased its stake in shares of Celsius by 200.0% in the 4th quarter. Phoenix Wealth Advisors now owns 7,440 shares of the company’s stock worth $439,000 after acquiring an additional 4,960 shares in the last quarter. 60.95% of the stock is currently owned by institutional investors.

Celsius Trading Up 3.2 %

CELH opened at $72.03 on Wednesday. The company has a market cap of $16.64 billion, a price-to-earnings ratio of 93.14, a PEG ratio of 2.01 and a beta of 1.86. The company’s 50 day moving average is $79.25 and its 200 day moving average is $64.58. Celsius Holdings, Inc. has a 12-month low of $29.91 and a 12-month high of $99.62.

Celsius (NASDAQ:CELH) last posted its quarterly earnings data on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.16 by $0.01. The company had revenue of $347.44 million for the quarter, compared to the consensus estimate of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm’s revenue was up 95.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.01 earnings per share. As a group, analysts predict that Celsius Holdings, Inc. will post 1.09 EPS for the current fiscal year.

Insider Buying and Selling

In related news, major shareholder Deborah Desantis sold 128,339 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $44.02, for a total value of $5,649,482.78. Following the transaction, the insider now owns 30,711,936 shares of the company’s stock, valued at $1,351,939,422.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other Celsius news, Director Nicholas Castaldo sold 165,000 shares of Celsius stock in a transaction that occurred on Monday, March 4th. The shares were sold at an average price of $83.33, for a total transaction of $13,749,450.00. Following the transaction, the director now owns 352,864 shares of the company’s stock, valued at $29,404,157.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Deborah Desantis sold 128,339 shares of Celsius stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $44.02, for a total transaction of $5,649,482.78. Following the transaction, the insider now directly owns 30,711,936 shares in the company, valued at approximately $1,351,939,422.72. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 780,433 shares of company stock valued at $49,149,715. 2.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have weighed in on CELH. Roth Mkm raised their price objective on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. UBS Group raised their price objective on shares of Celsius from $73.00 to $99.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Maxim Group raised their price objective on shares of Celsius from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Stifel Nicolaus raised their price objective on shares of Celsius from $67.00 to $90.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Finally, Stifel Europe raised their price objective on shares of Celsius from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 18th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $85.10.

Celsius Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.